Role for Lipids in the Maintenance of Chemokine and T-Cell Receptor Signaling

脂质在维持趋化因子和 T 细胞受体信号传导中的作用

基本信息

  • 批准号:
    7732321
  • 负责人:
  • 金额:
    $ 8.5万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
  • 资助国家:
    美国
  • 起止时间:
  • 项目状态:
    未结题

项目摘要

Lipid rafts play an important role in signal integration and cellular activation of a number of cytokine and growth factor receptors. Flotillin proteins have recently been shown to be recruited to lipid raft microdomains upon cellular activation and have been implicated in neural cell regeneration, receptor signaling and lymphocyte activation. However, little is known about the relevance of the flotillin proteins in T cell responses to chemoattractant stimulation. To this end, cytoplasmic and lipid raft fractions from human T cells were analyzed for flotillin protein redistribution prior to and after CXCL12 stimulation. Flotillin-1 but not flotillin-2 redistributes to lipid rafts upon CXCR4 ligation. Moreover, in CXCL12-treated T cells, flotillin-1 also associates with several raft proteins including LAT, Lck, CD48 and CD11a. In addition, an increase in CXCR4 association with flotillin-1 in lipid rafts was observed after chemokine treatment. RNAi technology was also utilized to inhibit the expression of flotillin-1 resulting in an inhibition of CXCL12-mediated signaling, function and CXCR4 recruitment into lipid rafts. Together, these data suggest that the association of flotillin-1 with lipid raft during chemokine exposure may play an important role in chemokine receptor recruitment to and signaling in lipid rafts and possibly in leading edge formation. Overall, we believe that a greater understanding of the various signaling and cell surface proteins associated with lipid rafts may provide insight into age-related alterations in cell signaling and trafficking. Additional studies have also revealed that dexamethasone (DM)-treated T cells demonstrate enhanced migration in response to the chemokine CXCL12, possibly through altering the cell membranes and rafts or through direct interaction with the chemokine and T-cell receptor signaling pathways. DM is a synthetic member of the glucocorticoid (GC) class of hormones that possesses anti-inflammatory and immunosuppressant activity and is commonly utilized to treat chronic inflammatory disorders, severe allergies and other disease states. While glucocorticoids are known to mediate well-defined transcriptional effects via GC receptors, there is increasing evidence that GCs also initiate rapid non-genomic signaling events in a variety of cell types. Here, we report that dexamethasone appears to induce the phosphorylation of Lck and the activation of other down stream mediators including p59Fyn, Zap70, Rac1 and Vav in resting but not activated human T cells. DM treatment also appears to augment CXCL12-mediated signaling in resting T cells through its cell surface receptor, CXCR4 resulting in the enhanced actin polymerization and cell migration upon ligand exposure. Lck was found to be a critical intermediate in these DM-induced signaling activities. Moreover, DM-mediated Lck phosphorylation in T cells was dependent on the presence of both the glucocorticoid receptor and the CD45 molecule. Overall, these results elucidate additional non-genomic effects of DM on resting human T cells, inducing Lck activation and augmenting chemokine signaling and function.
脂筏在多种细胞因子和生长因子受体的信号整合和细胞激活中发挥重要作用。最近发现,Flotillin蛋白在细胞激活时被招募到脂筏微域,并与神经细胞再生、受体信号转导和淋巴细胞激活有关。然而,关于Flotillin蛋白在T细胞对化学诱导剂刺激的反应中的相关性,人们知之甚少。为此,我们分析了CXCL12刺激前后人T细胞胞浆和脂筏部分的Flotillin蛋白再分布情况。当CXCR4结扎时,Flotillin-1而不是Flotillin-2重新分布到脂筏上。此外,在CXCL12处理的T细胞中,Flotillin-1还与LAT、Lck、CD48和CD11a等多种RAFT蛋白结合。此外,经趋化因子治疗后,脂筏中CXCR4与Flotillin-1的相关性增加。RNAi技术也被用来抑制Flotillin-1的表达,从而抑制CXCL12介导的信号、功能和CXCR4在脂筏中的募集。综上所述,这些数据表明,在趋化因子暴露期间,fltillin-1与脂筏的联系可能在趋化因子受体在脂筏中的募集和信号传递中发挥重要作用,并可能在前沿的形成中发挥重要作用。总体而言,我们认为,更好地了解与脂筏相关的各种信号和细胞表面蛋白可能有助于洞察细胞信号和运输中与年龄相关的变化。 其他研究也表明,地塞米松(DM)处理的T细胞对趋化因子CXCL12的反应表现出增强的迁移,可能是通过改变细胞膜和筏子,或者通过与趋化因子和T细胞受体信号通路的直接相互作用。糖尿病是糖皮质激素(GC)类激素的合成成员,具有抗炎和免疫抑制活性,通常用于治疗慢性炎症性疾病、严重过敏和其他疾病状态。虽然已知糖皮质激素通过GC受体介导明确的转录效应,但越来越多的证据表明,GC也在各种类型的细胞中启动快速的非基因组信号事件。在这里,我们报告地塞米松似乎诱导静息但不激活的人T细胞中Lck的磷酸化和其他下游介质的激活,包括p59Fyn,ZAP70,rac1和Vav。DM治疗似乎还通过其细胞表面受体CXCR4增强CXCL12介导的静息T细胞信号传递,从而在配体暴露时促进肌动蛋白聚合和细胞迁移。在DM诱导的这些信号活动中,LCK被发现是一个关键的中间体。此外,DM介导的T细胞Lck磷酸化依赖于糖皮质激素受体和CD45分子的存在。总体而言,这些结果阐明了DM对静息的人类T细胞、诱导LCK激活和增强趋化因子信号和功能的额外非基因组效应。

项目成果

期刊论文数量(4)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Membrane incorporation of 22-hydroxycholesterol inhibits chemokine receptor activity.
22-羟基胆固醇的膜掺入抑制趋化因子受体活性。
  • DOI:
    10.1016/s0014-4827(03)00063-6
  • 发表时间:
    2003
  • 期刊:
  • 影响因子:
    3.7
  • 作者:
    Nguyen,DzungH;Taub,DennisD
  • 通讯作者:
    Taub,DennisD
{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

DENNIS D. TAUB其他文献

DENNIS D. TAUB的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('DENNIS D. TAUB', 18)}}的其他基金

Phenotypic And Functional Changes In Circulating T Cells
循环 T 细胞的表型和功能变化
  • 批准号:
    6530497
  • 财政年份:
  • 资助金额:
    $ 8.5万
  • 项目类别:
Thymic Involution And Age-associated Changes In T Cells
T 细胞的胸腺退化和年龄相关变化
  • 批准号:
    6530518
  • 财政年份:
  • 资助金额:
    $ 8.5万
  • 项目类别:
Homocysteine Stimulates Human T Cell Effector Cell
同型半胱氨酸刺激人类 T 细胞效应细胞
  • 批准号:
    6530501
  • 财政年份:
  • 资助金额:
    $ 8.5万
  • 项目类别:
Immunoregulatory and Adjuvant effects of Hormones on the
激素对免疫调节和辅助作用
  • 批准号:
    6674114
  • 财政年份:
  • 资助金额:
    $ 8.5万
  • 项目类别:
Mechanisms that Regulate Thymic Involution and Age-Assoc
调节胸腺复旧和年龄相关的机制
  • 批准号:
    6674124
  • 财政年份:
  • 资助金额:
    $ 8.5万
  • 项目类别:
Characterization of Immune Alterations Associated with the Aging Process
与衰老过程相关的免疫改变的特征
  • 批准号:
    8552317
  • 财政年份:
  • 资助金额:
    $ 8.5万
  • 项目类别:
Gene Expression Induced by HIV-1 and Chemokine Receptor
HIV-1 和趋化因子受体诱导的基因表达
  • 批准号:
    6969410
  • 财政年份:
  • 资助金额:
    $ 8.5万
  • 项目类别:
Mechanisms that Regulate Thymic Involution and Age-Assoc
调节胸腺复旧和年龄相关的机制
  • 批准号:
    6969413
  • 财政年份:
  • 资助金额:
    $ 8.5万
  • 项目类别:
Novel Interactions Between the Immune and Neuroendocrine Systems
免疫系统和神经内分泌系统之间的新相互作用
  • 批准号:
    7964048
  • 财政年份:
  • 资助金额:
    $ 8.5万
  • 项目类别:
Mechanisms that Regulate Thymic Involution and Age-Associated Changes in T-Cells
T 细胞胸腺复旧和年龄相关变化的调节机制
  • 批准号:
    7964051
  • 财政年份:
  • 资助金额:
    $ 8.5万
  • 项目类别:

相似海外基金

Construction of affinity sensors using high-speed oscillation of nanomaterials
利用纳米材料高速振荡构建亲和传感器
  • 批准号:
    23H01982
  • 财政年份:
    2023
  • 资助金额:
    $ 8.5万
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
Affinity evaluation for development of polymer nanocomposites with high thermal conductivity and interfacial molecular design
高导热率聚合物纳米复合材料开发和界面分子设计的亲和力评估
  • 批准号:
    23KJ0116
  • 财政年份:
    2023
  • 资助金额:
    $ 8.5万
  • 项目类别:
    Grant-in-Aid for JSPS Fellows
Development of High-Affinity and Selective Ligands as a Pharmacological Tool for the Dopamine D4 Receptor (D4R) Subtype Variants
开发高亲和力和选择性配体作为多巴胺 D4 受体 (D4R) 亚型变体的药理学工具
  • 批准号:
    10682794
  • 财政年份:
    2023
  • 资助金额:
    $ 8.5万
  • 项目类别:
Platform for the High Throughput Generation and Validation of Affinity Reagents
用于高通量生成和亲和试剂验证的平台
  • 批准号:
    10598276
  • 财政年份:
    2023
  • 资助金额:
    $ 8.5万
  • 项目类别:
Collaborative Research: DESIGN: Co-creation of affinity groups to facilitate diverse & inclusive ornithological societies
合作研究:设计:共同创建亲和团体以促进多元化
  • 批准号:
    2233343
  • 财政年份:
    2023
  • 资助金额:
    $ 8.5万
  • 项目类别:
    Standard Grant
Collaborative Research: DESIGN: Co-creation of affinity groups to facilitate diverse & inclusive ornithological societies
合作研究:设计:共同创建亲和团体以促进多元化
  • 批准号:
    2233342
  • 财政年份:
    2023
  • 资助金额:
    $ 8.5万
  • 项目类别:
    Standard Grant
Molecular mechanisms underlying high-affinity and isotype switched antibody responses
高亲和力和同种型转换抗体反应的分子机制
  • 批准号:
    479363
  • 财政年份:
    2023
  • 资助金额:
    $ 8.5万
  • 项目类别:
    Operating Grants
Deconstructed T cell antigen recognition: Separation of affinity from bond lifetime
解构 T 细胞抗原识别:亲和力与键寿命的分离
  • 批准号:
    10681989
  • 财政年份:
    2023
  • 资助金额:
    $ 8.5万
  • 项目类别:
CAREER: Engineered Affinity-Based Biomaterials for Harnessing the Stem Cell Secretome
职业:基于亲和力的工程生物材料用于利用干细胞分泌组
  • 批准号:
    2237240
  • 财政年份:
    2023
  • 资助金额:
    $ 8.5万
  • 项目类别:
    Continuing Grant
ADVANCE Partnership: Leveraging Intersectionality and Engineering Affinity groups in Industrial Engineering and Operations Research (LINEAGE)
ADVANCE 合作伙伴关系:利用工业工程和运筹学 (LINEAGE) 领域的交叉性和工程亲和力团体
  • 批准号:
    2305592
  • 财政年份:
    2023
  • 资助金额:
    $ 8.5万
  • 项目类别:
    Continuing Grant
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了